Piper Jaffray Comments on ONXX; Sees Busy Quarter for Kidney Cancer Drugs
Tweet Send to a Friend
Piper Jaffray making comments on Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX), saying they expect a busy Q4 for kidney cancer ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
